Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Site News
Market: Market:

Acasti Pharma (ACST)

Acasti Pharma (ACST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Acasti Pharma Announces Annual Grants of Performance Stock Options Globe Newswire - Wed Jun 22, 5:10PM CDT

LAVAL, Québec, June 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage,...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma Reports Fiscal Year 2022 Operational Results Globe Newswire - Tue Jun 21, 7:00AM CDT

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, June 21, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”)...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call Globe Newswire - Thu Jun 16, 3:15PM CDT

Call to be held on Tuesday, June 21st at 1:00 PM Eastern Time...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints Globe Newswire - Wed May 18, 6:30AM CDT

Bioavailability of IV GTX-104 compared favorably with the oral formulation of nimodipine, and no serious adverse events observed for GTX-104 Phase 3...

ACST.VN : 1.110 (-0.89%)
ACST : 0.8313 (-3.10%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 AccessWire - Mon May 16, 12:20PM CDT

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 0.8313 (-3.10%)
LPTH : 1.2600 (+2.44%)
RCAT : 2.03 (-0.49%)
IONM : 1.4727 (+0.87%)
PYR : 1.9900 (+2.58%)
OSS : 3.90 (-1.02%)
MODD : 5.11 (-1.35%)
STRN : 1.6600 (unch)
AEYE : 6.12 (+1.83%)
SMFL : 0.5222 (-2.36%)
LFMD : 2.07 (+1.47%)
SURG : 4.85 (+0.41%)
Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th AccessWire - Thu May 12, 7:00AM CDT

LAVAL, QC / ACCESSWIRE / May 12, 2022 / Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST)(TSXV:ACST), today announced that Jan D'Alvise, Chief Executive Officer, has been invited to present...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th Globe Newswire - Mon Apr 25, 7:30AM CDT

LAVAL, Québec, April 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors Globe Newswire - Fri Mar 25, 6:30AM CDT

LAVAL, Quebec, March 25, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST) today announces that it...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan Globe Newswire - Tue Mar 22, 6:30AM CDT

LAVAL, Québec, March 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), announces the...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)
Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th Globe Newswire - Wed Mar 9, 7:30AM CST

LAVAL, Quebec, March 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announced that Jan...

ACST : 0.8313 (-3.10%)
ACST.VN : 1.110 (-0.89%)

Barchart Exclusives

2 BDC Stocks Yield Over 10% With Excellent Covered Call Plays Barchart - Fri Jul 1, 12:39PM CDT
These 2 business development companies (BDCs) yield over 10%, even before some extra quarterly dividends they have been issuing. In addition, they off excellent covered call opportunities for investors. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' : 'America/Chicago' ]] CDT
Reserve Your Spot